Report Detail
Global Insulin API Market Growth 2019-2024
- RnM2872661 |
- 04 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
The overall domestic policy for the development of insulin API is supported. Local governments have a lot of policies to support the development of the industry. But in recent years environmental protection requirements for the fermentation industry are also getting higher and higher.
According to this study, over the next five years the Insulin API market will register a 4.2% CAGR in terms of revenue, the global market size will reach US$ 2120 million by 2024, from US$ 1660 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Insulin API business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin API market by product type, application, key manufacturers and key regions and countries.
This study considers the Insulin API value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Regular Human Insulin
Insulin Analogue
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Fast-acting
Premix
Long-acting
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
Julphar Diabetes
Wockhardt
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Insulin API consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Insulin API market by identifying its various subsegments.
Focuses on the key global Insulin API manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin API with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Insulin API submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Insulin API Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Insulin API Consumption 2014-2024
- 2.1.2 Insulin API Consumption CAGR by Region
- 2.2 Insulin API Segment by Type
- 2.2.1 Regular Human Insulin
- 2.2.2 Insulin Analogue
- 2.3 Insulin API Consumption by Type
- 2.3.1 Global Insulin API Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Insulin API Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Insulin API Sale Price by Type (2014-2019)
- 2.4 Insulin API Segment by Application
- 2.4.1 Fast-acting
- 2.4.2 Premix
- 2.4.3 Long-acting
- 2.5 Insulin API Consumption by Application
- 2.5.1 Global Insulin API Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Insulin API Value and Market Share by Application (2014-2019)
- 2.5.3 Global Insulin API Sale Price by Application (2014-2019)
3 Global Insulin API by Players
- 3.1 Global Insulin API Sales Market Share by Players
- 3.1.1 Global Insulin API Sales by Players (2017-2019)
- 3.1.2 Global Insulin API Sales Market Share by Players (2017-2019)
- 3.2 Global Insulin API Revenue Market Share by Players
- 3.2.1 Global Insulin API Revenue by Players (2017-2019)
- 3.2.2 Global Insulin API Revenue Market Share by Players (2017-2019)
- 3.3 Global Insulin API Sale Price by Players
- 3.4 Global Insulin API Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Insulin API Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Insulin API Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Insulin API by Regions
- 4.1 Insulin API by Regions
- 4.1.1 Global Insulin API Consumption by Regions
- 4.1.2 Global Insulin API Value by Regions
- 4.2 Americas Insulin API Consumption Growth
- 4.3 APAC Insulin API Consumption Growth
- 4.4 Europe Insulin API Consumption Growth
- 4.5 Middle East & Africa Insulin API Consumption Growth
5 Americas
- 5.1 Americas Insulin API Consumption by Countries
- 5.1.1 Americas Insulin API Consumption by Countries (2014-2019)
- 5.1.2 Americas Insulin API Value by Countries (2014-2019)
- 5.2 Americas Insulin API Consumption by Type
- 5.3 Americas Insulin API Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Insulin API Consumption by Countries
- 6.1.1 APAC Insulin API Consumption by Countries (2014-2019)
- 6.1.2 APAC Insulin API Value by Countries (2014-2019)
- 6.2 APAC Insulin API Consumption by Type
- 6.3 APAC Insulin API Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Insulin API by Countries
- 7.1.1 Europe Insulin API Consumption by Countries (2014-2019)
- 7.1.2 Europe Insulin API Value by Countries (2014-2019)
- 7.2 Europe Insulin API Consumption by Type
- 7.3 Europe Insulin API Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Insulin API by Countries
- 8.1.1 Middle East & Africa Insulin API Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Insulin API Value by Countries (2014-2019)
- 8.2 Middle East & Africa Insulin API Consumption by Type
- 8.3 Middle East & Africa Insulin API Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Insulin API Distributors
- 10.3 Insulin API Customer
11 Global Insulin API Market Forecast
- 11.1 Global Insulin API Consumption Forecast (2019-2024)
- 11.2 Global Insulin API Forecast by Regions
- 11.2.1 Global Insulin API Forecast by Regions (2019-2024)
- 11.2.2 Global Insulin API Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Insulin API Forecast by Type
- 11.8 Global Insulin API Forecast by Application
12 Key Players Analysis
- 12.1 Novo Nordisk
- 12.1.1 Company Details
- 12.1.2 Insulin API Product Offered
- 12.1.3 Novo Nordisk Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novo Nordisk News
- 12.2 Sanofi-Aventis
- 12.2.1 Company Details
- 12.2.2 Insulin API Product Offered
- 12.2.3 Sanofi-Aventis Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sanofi-Aventis News
- 12.3 Eli Lilly
- 12.3.1 Company Details
- 12.3.2 Insulin API Product Offered
- 12.3.3 Eli Lilly Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Eli Lilly News
- 12.4 Tonghua Dongbao
- 12.4.1 Company Details
- 12.4.2 Insulin API Product Offered
- 12.4.3 Tonghua Dongbao Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Tonghua Dongbao News
- 12.5 United Laboratory
- 12.5.1 Company Details
- 12.5.2 Insulin API Product Offered
- 12.5.3 United Laboratory Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 United Laboratory News
- 12.6 Biocon
- 12.6.1 Company Details
- 12.6.2 Insulin API Product Offered
- 12.6.3 Biocon Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Biocon News
- 12.7 Torrent Pharma
- 12.7.1 Company Details
- 12.7.2 Insulin API Product Offered
- 12.7.3 Torrent Pharma Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Torrent Pharma News
- 12.8 Amphastar
- 12.8.1 Company Details
- 12.8.2 Insulin API Product Offered
- 12.8.3 Amphastar Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Amphastar News
- 12.9 Ganlee
- 12.9.1 Company Details
- 12.9.2 Insulin API Product Offered
- 12.9.3 Ganlee Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Ganlee News
- 12.10 Julphar Diabetes
- 12.10.1 Company Details
- 12.10.2 Insulin API Product Offered
- 12.10.3 Julphar Diabetes Insulin API Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Julphar Diabetes News
- 12.11 Wockhardt
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Insulin API . Industry analysis & Market Report on Insulin API is a syndicated market report, published as Global Insulin API Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Insulin API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
